These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 25435121)

  • 41. Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.
    Parodi F; Passoni L; Massimo L; Luksch R; Gambini C; Rossi E; Zuffardi O; Pistoia V; Pezzolo A
    OMICS; 2011 Mar; 15(3):113-21. PubMed ID: 21319993
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Management of Neonatal Neuroblastoma.
    Interiano RB; Davidoff AM
    Curr Pediatr Rev; 2015; 11(3):179-87. PubMed ID: 26168943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
    Fletcher JI; Ziegler DS; Trahair TN; Marshall GM; Haber M; Norris MD
    Nat Rev Cancer; 2018 Jun; 18(6):389-400. PubMed ID: 29632319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroblastoma.
    Chung C; Boterberg T; Lucas J; Panoff J; Valteau-Couanet D; Hero B; Bagatell R; Hill-Kayser CE
    Pediatr Blood Cancer; 2021 May; 68 Suppl 2(Suppl 2):e28473. PubMed ID: 33818884
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New Approaches Towards Targeted Therapy for Childhood Neuroblastoma.
    Dalianis T; Lukoseviciute M; Holzhauser S; Kostopoulou ON
    Anticancer Res; 2023 Sep; 43(9):3829-3839. PubMed ID: 37648295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets.
    Katta SS; Nagati V; Paturi ASV; Murakonda SP; Murakonda AB; Pandey MK; Gupta SC; Pasupulati AK; Challagundla KB
    J Control Release; 2023 May; 357():444-459. PubMed ID: 37023798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current management of neuroblastoma and future direction.
    Pastor ER; Mousa SA
    Crit Rev Oncol Hematol; 2019 Jun; 138():38-43. PubMed ID: 31092383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biology and treatment of neuroblastoma.
    Castleberry RP
    Pediatr Clin North Am; 1997 Aug; 44(4):919-37. PubMed ID: 9286292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic predisposition and chromosome instability in neuroblastoma.
    Tonini GP; Capasso M
    Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Update on neuroblastoma.
    Newman EA; Abdessalam S; Aldrink JH; Austin M; Heaton TE; Bruny J; Ehrlich P; Dasgupta R; Baertschiger RM; Lautz TB; Rhee DS; Langham MR; Malek MM; Meyers RL; Nathan JD; Weil BR; Polites S; Madonna MB;
    J Pediatr Surg; 2019 Mar; 54(3):383-389. PubMed ID: 30305231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroblastoma update.
    Henry MC; Tashjian DB; Breuer CK
    Curr Opin Oncol; 2005 Jan; 17(1):19-23. PubMed ID: 15608507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuroblastoma: An Updated Review on Biology and Treatment.
    Mallepalli S; Gupta MK; Vadde R
    Curr Drug Metab; 2019; 20(13):1014-1022. PubMed ID: 31878853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroblastoma.
    Davidoff AM
    Semin Pediatr Surg; 2012 Feb; 21(1):2-14. PubMed ID: 22248965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic discoveries and treatment advances in neuroblastoma.
    Bagatell R; Cohn SL
    Curr Opin Pediatr; 2016 Feb; 28(1):19-25. PubMed ID: 26576010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A finite mixture survival model to characterize risk groups of neuroblastoma.
    Hunsberger S; Albert PS; London WB
    Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Narrative review: precision medicine applications in neuroblastoma-current status and future prospects.
    Zhou J; Du H; Cai W
    Transl Pediatr; 2024 Jan; 13(1):164-177. PubMed ID: 38323175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic susceptibility to neuroblastoma: current knowledge and future directions.
    Ritenour LE; Randall MP; Bosse KR; Diskin SJ
    Cell Tissue Res; 2018 May; 372(2):287-307. PubMed ID: 29589100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis.
    Ognibene M; De Marco P; Amoroso L; Cangelosi D; Zara F; Parodi S; Pezzolo A
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nervous system: Embryonal tumors: Neuroblastoma.
    Pudela C; Balyasny S; Applebaum MA
    Atlas Genet Cytogenet Oncol Haematol; 2020 Jul; 24(7):284-290. PubMed ID: 32296467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the Management of Neuroblastoma.
    Qadir MI; Ahmed B; Noreen S
    Crit Rev Eukaryot Gene Expr; 2024; 34(2):1-13. PubMed ID: 38073438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.